Jean Luc Dubois-Rande
Overview
Explore the profile of Jean Luc Dubois-Rande including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension
Abid S, Houssaini A, Mouraret N, Marcos E, Amsellem V, Wan F, et al.
Arterioscler Thromb Vasc Biol
. 2013 Dec;
34(2):304-12.
PMID: 24334871
Objective: Carbon monoxide-releasing molecules (CORMs) represent a pharmacological alternative to CO gas inhalation. Here, we questioned whether CORM-3, a well-characterized water-soluble CORM, could prevent and reverse pulmonary hypertension (PH) in...
2.
Maison P, Desamericq G, Hemery F, Elie N, Delvolgo A, Dubois-Rande J, et al.
Eur J Clin Pharmacol
. 2012 Sep;
69(4):901-8.
PMID: 22993100
Purpose: We previously reported that chronic heart failure (CHF) treatments reduce the duration of hospitalisation, even in elderly patients. The present study aimed to determine whether CHF treatment also provides...
3.
Obame F, Plin-Mercier C, Assaly R, Zini R, Dubois-Rande J, Berdeaux A, et al.
J Pharmacol Exp Ther
. 2008 Apr;
326(1):252-8.
PMID: 18434587
Morphine has been shown to protect the myocardium against ischemia-reperfusion injury through inhibition of glycogen synthase kinase-3beta (GSK-3beta). Given that GSK-3beta is known to modulate the mitochondrial permeability transition pore...
4.
Maison P, Cunin P, Hemery F, Fric F, Elie N, Delvolgo A, et al.
Eur J Clin Pharmacol
. 2005 Jun;
61(5-6):445-51.
PMID: 15940531
Objectives: Trials in chronic heart failure (CHF) include few patients older than 75 years, who represent a large proportion of CHF patients. We evaluated the influence of age on CHF-medication...
5.
Lellouche N, Berthier R, Mekontso-Dessap A, Braconnier F, Monin J, Duval A, et al.
Am J Cardiol
. 2005 May;
95(11):1380-2.
PMID: 15904651
After successful external cardioversion, the rate of recurrence of atrial fibrillation remains high. The hypothesis that plasma B-type natriuretic peptide could predict the recurrence of atrial fibrillation at 1 year...
6.
Merlet P, Hittinger L, Dubois-Rande J, Castaigne A
J Nucl Med
. 2002 Apr;
43(4):536-9.
PMID: 11937599
No abstract available.